Claritev Corporation (CTEV)

Price$26.99

Value ScoreC

Growth ScoreC

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-60.39%

Price vs S&P 500 (4W)-4.21%

VGM Score55.66

Market Capitalization$428.24M

All Metrics

P/CF (Annual)3.65x

Book Value / Share (Quarterly)$0.90

Revenue Growth (3Y)-3.66%

Cash Flow / Share (Quarterly)$-2.11

Price vs S&P 500 (YTD)-52.17%

Gross Margin (TTM)73.23%

Net Profit Margin (TTM)-29.27%

EPS (TTM)$-17.32

10-Day Avg Trading Volume0.32M

EPS Excl Extra (TTM)$-17.32

Revenue Growth (5Y)0.58%

EPS (Annual)$-17.30

ROI (Annual)-35.72%

Gross Margin (Annual)73.75%

Net Profit Margin (5Y Avg)-51.95%

Cash / Share (Quarterly)$1.25

Revenue Growth QoQ (YoY)5.77%

ROA (Last FY)-5.82%

Revenue Growth TTM (YoY)5.53%

EBITD / Share (TTM)$28.50

ROE (5Y Avg)-402.44%

Operating Margin (TTM)2.60%

Cash Flow / Share (Annual)$-0.74

P/B Ratio28.89x

P/B Ratio (Quarterly)22.87x

Net Income / Employee (Annual)$-94,800

EV / Revenue (TTM)5.23x

Net Interest Coverage (TTM)0.05x

ROA (TTM)-5.79%

EV / EBITDA (TTM)10.86x

EPS Incl Extra (Annual)$-17.30

Current Ratio (Annual)0.86x

Quick Ratio (Quarterly)1.07x

3-Month Avg Trading Volume0.19M

52-Week Price Return-30.11%

Revenue / Employee (TTM)$326,300

P/S Ratio (Annual)0.44x

Asset Turnover (Annual)0.20x

52-Week High$74.07

Operating Margin (5Y Avg)-25.66%

EPS Excl Extra (Annual)$-17.30

CapEx CAGR (5Y)12.85%

26-Week Price Return-44.46%

Quick Ratio (Annual)0.69x

13-Week Price Return77.28%

Total Debt / Equity (Annual)53.83x

Current Ratio (Quarterly)1.28x

Enterprise Value$5.12B

Revenue / Share Growth (5Y)96.76%

Asset Turnover (TTM)0.20x

Revenue / Employee (Annual)$321,800

Pretax Margin (Annual)-38.64%

Cash / Share (Annual)$1.02

3-Month Return Std Dev142.05%

Gross Margin (5Y Avg)77.79%

Net Income / Employee (TTM)$-95,500

EBITDA CAGR (5Y)23.73%

EBITDA Interim CAGR (5Y)-8.46%

ROE (Last FY)-1958.81%

Net Interest Coverage (Annual)0.06x

EPS Basic Excl Extra (Annual)$-17.30

P/FCF (TTM)5.87x

Receivables Turnover (TTM)8.35x

Total Debt / Equity (Quarterly)311.26x

EPS Incl Extra (TTM)$-17.32

Receivables Turnover (Annual)8.88x

ROI (TTM)-24.66%

P/S Ratio (TTM)0.44x

Pretax Margin (5Y Avg)-55.97%

Revenue / Share (Annual)$58.74

Price vs S&P 500 (52W)-58.31%

Year-to-Date Return-41.24%

5-Day Price Return15.92%

EPS Normalized (Annual)$-17.30

ROA (5Y Avg)-9.12%

Net Profit Margin (Annual)-29.45%

Month-to-Date Return3.25%

EBITD / Share (Annual)$28.32

Operating Margin (Annual)2.08%

LT Debt / Equity (Annual)53.67x

P/CF (TTM)4.21x

ROI (5Y Avg)-10.36%

LT Debt / Equity (Quarterly)310.26x

EPS Basic Excl Extra (TTM)$-17.32

P/B Ratio (Annual)2.83x

Pretax Margin (TTM)-38.41%

Book Value / Share (Annual)$5.19

Price vs S&P 500 (13W)67.53%

Beta0.74x

P/FCF (Annual)6.81x

Revenue / Share (TTM)$58.64

ROE (TTM)-517.57%

52-Week Low$11.50

vGradeC

gGradeC

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-4.41est. -4.09

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.18

Industry Peers — Business Services(116)

Symbol	Value Score	Growth Score	Momentum Score	Price
CTEVClaritev Corporation	C	C	B	$26.99
VVISA Inc.	D	C	C	$322.77
MAMastercard Incorporated	D	B	C	$495.25
UBERUber Technologies, Inc.	C	C	C	$73.77
ACNAccenture PLC	B	C	D	$196.59
MELIMercado Libre, Inc	C	B	C	$1730.98
DASHDoorDash, Inc. Class A Common Stock	D	B	C	$164.78
RELXRELX PLC	D	C	C	$34.60
EBAYeBay Inc	D	D	B	$110.35
MSCIMSCI, Inc.	D	C	B	$643.83
BABAAlibaba Group Holding Limited American Depositary Shares, each represents eight Ordinary Shares	C	D	C	$125.40

About

Claritev Corp provides healthcare technology and data analytics solutions designed to improve cost management, transparency, and quality across the U.S. healthcare system. The company delivers customized, tech-enabled services encompassing payment integrity, network optimization, and revenue cycle analytics for healthcare providers and payers. Its data-driven platform helps organizations reduce costs while enhancing operational efficiency and affordability.